Invention Grant
- Patent Title: Aurora A kinase inhibitor
-
Application No.: US15407766Application Date: 2017-01-17
-
Publication No.: US10010540B2Publication Date: 2018-07-03
- Inventor: James Robert Henry
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent James B Myers; Elizabeth A. Dingess-Hammond; Danica Hostettler
- Main IPC: A61K31/4545
- IPC: A61K31/4545
Abstract:
The present invention provides an aminopyridine compound, or a pharmaceutically acceptable salt thereof, that inhibits Aurora A and, therefore may be useful in treating cancer.
Public/Granted literature
- US20170119751A1 AURORA A KINASE INHIBITOR Public/Granted day:2017-05-04
Information query
IPC分类:
